Sycai Medical is an innovative startup founded in 2020 and headquartered in Spain. The company operates at the intersection of AI and Health Care, focusing on developing AI-based software for the early diagnosis and non-invasive monitoring of abdominal cancer.
Sycai Medical distinguishes itself with a unique multiorgan product that leverages #AI and #BigData to assist radiologists in detecting and characterizing abdominal lesions on CT scans and MRIs. Additionally, it offers a predictive analysis of the likelihood of lesions becoming cancerous, accentuating its potential to revolutionize early-stage pancreatic cancer diagnosis and improve patient quality of life.
Most recently, the company secured a €3.00K grant investment on 12 October 2023 from Hospitales San Roque. This strategic collaboration underscores its credibility and potential for growth in the competitive medical AI landscape.